We are live on ! Find out more
BTMDW

Biote Corp. Warrant
BTMDW

Delisted

BTMDW was delisted on the 6th of July, 2023.

Back to rankings

39 hedge funds and large institutions have $4.46M invested in Biote Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more capital invested

Capital invested by funds: $3.34M → $4.46M (+$1.12M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

9% less funds holding

Funds holding: 43 → 39 (-4)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
39
Holders Change
-4
Holders Change %
-9.3%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
6
Closed
6
Calls
$222K
Puts
–
Net Calls
+$222K
Net Calls Change
-$701K

Top Buyers

Rank Fund Capital Flow
1
BCM
BlueCrest Capital Management
Jersey
+$6.87M
2
LP
LMR Partners
United Kingdom
+$128K
3
MC
Meteora Capital
Florida
+$123K
4
JFG
Jefferies Financial Group
New York
+$67.9K
5
DC
Diametric Capital
Massachusetts
+$54.5K

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$102K
2
OCAM
Owl Creek Asset Management
New York
-$80K
3
BP
BBR Partners
New York
-$44K
4
PCM
Prelude Capital Management
New York
-$21K
5
RCM
Radcliffe Capital Management
Pennsylvania
-$16.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
26
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$11.4K – – –
LIM
27
Longfellow Investment Management
Massachusetts
$10.7K -$4.09K -15,000 -30%
SBLIC
28
Security Benefit Life Insurance Company
Kansas
$8.75K – – –
PI
29
PEAK6 Investments
Illinois
$8.18K – – –
TCM
30
Tenor Capital Management
New York
$7.5K – – –
EH
31
EMG Holdings
Connecticut
$7.47K – – –
Bank of America
32
Bank of America
North Carolina
$6.25K – – –
Walleye Capital
33
Walleye Capital
New York
$6.01K – – –
WAM
34
Wolverine Asset Management
Illinois
$3.77K +$1.23K +4,510 +56%
Walleye Trading
35
Walleye Trading
New York
$3.38K – – –
DCM
36
Dupont Capital Management
Delaware
$2.15K – – –
AA
37
Ancora Advisors
Ohio
$2K – – –
CS
38
Credit Suisse
Switzerland
$1.03K – – –
FPA
39
First Pacific Advisors
California
$550 -$3 -12 -0.5%
WP
40
Woodline Partners
California
– -$102K -299,700 Closed
OCAM
41
Owl Creek Asset Management
New York
– -$80K -235,000 Closed
BP
42
BBR Partners
New York
– -$44K -127,675 Closed
PCM
43
Prelude Capital Management
New York
– -$21K -62,500 Closed
CAPTRUST Financial Advisors
44
CAPTRUST Financial Advisors
North Carolina
– -$6K -17,165 Closed
UBS Group
45
UBS Group
Switzerland
– -$2K -5,830 Closed
1
2

BTMDW Hedge Fund Activity: Q4 2022 in Review

39 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Biote Corp. Warrant (BTMDW) for Q4 2022, worth a combined $4.46M — up 33% from $3.34M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BTMDW and 3 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 6 added.

The largest buyer was BlueCrest Capital Management, adding an estimated $6.87M. The largest seller was Woodline Partners, exiting entirely with an estimated $102K sold.

  • 39 institutional investors held Biote Corp. Warrant (BTMDW) as of Q4 2022, down from 43 in Q3 2022.
  • Funds reported $4.46M of Biote Corp. Warrant stock for Q4 2022, up 33% quarter-over-quarter.
  • 3 funds opened new Biote Corp. Warrant positions in Q4 2022 and 6 closed out, a net change of -3 holders.
  • The largest Biote Corp. Warrant buyer in Q4 2022 was BlueCrest Capital Management, an estimated $6.87M added.
  • The largest Biote Corp. Warrant seller in Q4 2022 was Woodline Partners, an estimated $102K sold.

Based on aggregated 13F filings for Q4 2022.